Characterization of radiologically indeterminate lung lesions: 99mtc-depreotide spect versus f-fdg pet

Nuclear Medicine Communications

Volumn 27, Issue 6, 2006, Pages 507-514

  Ferran, Nuria ^a   Ricart, Yvonne ^a   Lopez, Marta ^b   Martinez Ballarin, Ignacio ^b   Roca, Manel ^b   Gámez, Cristina ^c   Carrerea, David ^c   Guirao, Sara ^c  

^a Hospitalet de Llobregat   (United States)

^b S Medicina Nuclear   (United States)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

18F FDG PET; Lung cancer; Pulmonary lesions

Indexed keywords

DEPREOTIDE TC 99M; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN; TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADRENAL METASTASIS; ANALYTIC METHOD; ASPIRATION BIOPSY; BONE METASTASIS; CARCINOID; CLINICAL ARTICLE; HISTOLOGY; INTERMETHOD COMPARISON; LUNG CANCER; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; ROC CURVE; THORAX SCINTISCANNING; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33746442107     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200606000-00006     Document Type: Article

References (17)

1. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging and management of non-small cell lung cancer. The Oncologist 2004; 9:633-642.
2. Tan BB, Flaherty KR, Kazerooni EA, Lannettoni MD, American College of Chest Physicians. The solitary pulmonary nodule. Chest 2003; 123:89S-96S.
3. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003; 348:2535-2542.
4. Swenson SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in the solitary pulmonary nodules:application to small radiologically indeterminate nodules. Arch Intern Med 1997; 57:849-855.
5. Goldsmith SJ, Kostnbsakoglu AA, Somrov S, Palestro CJ. Radionuclide imaging of thoracic malignancies. Thoracic Surg Clin 2004; 14:95-112.
6. O'Burme K, Carney D. Somatostatin and the lung. Lung Cancer 1993; 10:151-172.
7. Blum J, Handmarker H, Rinne N. The utility of somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules. Chest 1999; 115:224-232.
8. Vallabhajosula S, Moyer B, Lister-James J. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med 1996; 37:1016-1022.
9. 99mTc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117:1232-1238.
10. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16:1075-1084.
11. Kubota K, Matsuzava T, Fijiwara T, Ito M, Hutazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990; 31:1927-1932.
12. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine 18-FDG and PET. J Nucl Med 1996; 37:943-948.
13. Bury T, Rigo P. Contribution of positron emision tomography for the management of lung cancer. Rev Pneumol Clin 2000; 56:1506-1511.
14. Gould MK, Maclean CC, Kuschner WG, Rydizak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914-924.
15. 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med March 2005; Issue on line. ISSN 1619-7089.
16. Roberts PF, Follette DM, von Haag D, Park JA, Valk PE, Pounds TR, et al. Factors associated with false positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000; 70:1154-1159.
17. 18F-FDG for the evaluation of pulmonary nodules. J Nucl Med 2002; 43:273-278.